Recent Interviews

Dirk Graszt, CEO, Clean Logistics SE

Dirk Graszt
CEO | Clean Logistics SE
Trettaustr.32, 21107 Hamburg (DE)


Interview Clean Logistics: Hydrogen challenge to Daimler + Co.

Matthew Salthouse, CEO, Kainantu Resources

Matthew Salthouse
CEO | Kainantu Resources
3 Phillip Street #19-01 Royal Group Building, 048693 Singapore (SGP)

+65 6920 2020

Interview Kainantu Resources: "We hold the key to growth in the Asia-Pacific region".

Justin Reid, President and CEO, Troilus Gold Corp.

Justin Reid
President and CEO | Troilus Gold Corp.
36 Lombard Street, Floor 4, M5C 2X3 Toronto, Ontario (CAN)

+1 (647) 276-0050

Interview Troilus Gold: "We are convinced that Troilus is more than just a mine".

21. December 2020 | 07:50 CET

CureVac, EXMceuticals, Formycom - the undiscovered profiteers of the crisis!

  • Covid-19
Photo credits:

The Corona pandemic continues to be the dominant topic of our time. Not a day goes by when new achievements in the fight against the pandemic come to public attention. The battle against Covid-19 is becoming a multi-billion-dollar business. In addition to the well-known profiteers, the vaccine manufacturers BioNTech and Pfizer, Moderna and AstraZeneca and many smaller companies are also profiting. Their potential is still largely unknown on the stock market and is far from being fully exploited.

time to read: 2 minutes by Stefan Feulner
ISIN: CA30207T1049 , NL0015436031 , DE000A1EWVY8



Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author

Pandemic creates revaluation

The Nanorepro AG share, for example, was able to profit from the "boom". While the share price was below EUR 0.50 in March 2020, a rights issue is currently underway in which existing shareholders can subscribe to new shares at a subscription price of EUR 3.03 for 3.53 old shares. The Marburg-based Company has always been a rapid diagnostics manufacturer, primarily in health planning and prevention. Nanorepro AG is one of the innovation leaders and has more than 25 rapid tests in its portfolio - including an HIV test and five other tests for specialist medical use. The Corona antibody test, which is also offered, as well as several Corona antigens tests, have now helped the Company achieve a breakthrough.

Another positive example is Formycom AG. This Company was able to report initial successes in the development of the first drug against the coronavirus. After the announcement, the share price rose from EUR 33.50 to EUR 72.00 - within four days.

European Union pays

Things can also go fast for the medical cannabis company EXMceuticals. For the "BioBlockCOVID" project, a consortium led by Portuguese subsidiary EXMceuticals Portugal Lda received a Covid-19 grant of EUR 302,000 from the European Union and the Portuguese government. The goal is to study and develop a disinfectant to combat SARS-CoV-2.

Cannabis megatrend

In addition to the projects around combating Corona, EXMceuticals aims to become a large-scale producer of the highest-quality cannabis ingredients for the pharmaceutical market. To this end, the Canadian-based Company has positioned itself in the European market and owns an EU-certified processing facility in Portugal to extract active ingredients from cannabis plants.

Facing reassessment

At the moment, the signs are pointing to expansion. The refinery, for example, is to be significantly expanded. After successful expansion, EXMceuticals will be able to process up to 50,000 kilograms of flowers into oil per year. According to analysts, the European cannabis market alone will grow to approximately USD 2.50 billion in the next five years, and EXMceuticals would be one of the first players in the market. The finalized plans are already with banks and authorities. If they approve the financing, the purchasing of additional machines can be initiated immediately, and worldwide sales could be accelerated. Currently, the stock market value is around CAD 11.0 million. For a European first mover in the cannabis market, there would still be room for improvement after successful approval.

Welcome to the Club

Now CureVac has made it too. The vaccine manufacturer is allowed to go into mass production of its vaccine at its site in Tübingen. The Tübingen Regional Council announced Friday that a necessary permit has now been issued. "In the current situation, supporting companies in the research and development of active substances against the coronavirus has the highest priority," Regierungspräsident Klaus Tappeser announced. "We are creating a reliable legal framework for these companies as quickly as possible while maintaining strict procedural requirements." US competitor Moderna also got the green light from the US Food and Drug Administration.

The agency gave emergency approval for the vaccine, meaning that use of the drug could begin as early as Monday. After the incumbent US President Donald Trump celebrated with the tweet "Congratulations, the Moderna vaccine is now available", the statement was revised. At first, only those in need of protection get the vaccination, for the general population it will take months until enough funds are available.


Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author

Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.

Related comments:

04. February 2021 | 08:15 CET | by Nico Popp

BioNTech, Cardiol Therapeutics, Johnson & Johnson: biotech gems from the well-known to the unknown

  • Covid-19

If there's one industry that's rightfully making big profits these days, it's healthcare companies. The pandemic has kissed the industry awake. In addition to the current relevance around Covid treatment, test procedures, or even vaccinations, there is also a growing awareness that medical innovation depends on research. More and more investors are willing to push promising projects and the general conditions for this could not be better. There is a consensus in politics, society and business that health is the highest good.


02. November 2020 | 09:07 CET | by Stefan Feulner

Ballard Power, Saturn Oil & Gas, Amazon - The profiteers of the crisis!

  • Covid-19

The profiteers of the first wave of the Corona pandemic are seen from the most recently published quarterly figures. The well-known FAANG stocks Facebook, Amazon, Apple, Netflix and Alphabet (Google) were able to improve their balance sheets significantly. Besides some winners, the number of losers is much larger. These now either have to fight for survival or are swallowed cheaply by financially more robust competitors. The takeover wave should pick up speed in 2021, across all industries!


21. October 2020 | 12:42 CET | by Stefan Feulner

BioNTech, Valeo Pharma, Pfizer - Starting signal!

  • Covid-19

Who will make the race for the first approved Corona vaccine? Russia, China, and several North American suppliers are fighting for a place in the sun. The second and third parties should also benefit from the approval, as the demand is enormous among the nearly 8 billion inhabitants of the earth. One thing is clear; the winners of this almost macabre-sounding "Corona contest" will go through the roof. Those who receive late approval or no approval at all risk extinction. Admittedly, the world is looking at the long-awaited miracle cure. But there are easier ways for every individual to protect themselves against viruses.